AME Stock Overview
Manufactures and sells diagnostic medical devices in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Advanced Medical Equipment Spolka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł48.00 |
| 52 Week High | zł89.00 |
| 52 Week Low | zł36.50 |
| Beta | 0 |
| 11 Month Change | -15.94% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -24.29% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| AME | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -5.0% | -4.8% | -3.6% |
| 1Y | n/a | -10.1% | -0.01% |
Return vs Industry: Insufficient data to determine how AME performed against the Polish Medical Equipment industry.
Return vs Market: Insufficient data to determine how AME performed against the Polish Market.
Price Volatility
| AME volatility | |
|---|---|
| AME Average Weekly Movement | 16.2% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: AME's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: Insufficient data to determine AME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | n/a | n/a | diabetomat.pl/advanced-medical-equipment-s-a |
Advanced Medical Equipment Spolka Akcyjna manufactures and sells diagnostic medical devices in Poland. It offers Diabetomat, a medical device for testing sugar levels. The company was founded in 2022 and is based in Warsaw, Poland.
Advanced Medical Equipment Spolka Akcyjna Fundamentals Summary
| AME fundamental statistics | |
|---|---|
| Market cap | zł54.50m |
| Earnings (TTM) | zł0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs AME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AME income statement (TTM) | |
|---|---|
| Revenue | zł0 |
| Cost of Revenue | zł0 |
| Gross Profit | zł0 |
| Other Expenses | zł0 |
| Earnings | zł0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AME perform over the long term?
See historical performance and comparison